4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-038731
Chief Legal Officer sold 5,833 shares at $35.04 ($204,410)
- Chief Legal Officer acquired 5,833 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2024-03-27 | Option exercise 10b5-1 | +4,342 | $25.98 | $112,805 | 6,079 | D |
| Bizily Scott Chief Legal Officer | 2024-03-27 | Option exercise 10b5-1 | +1,491 | $25.98 | $38,736 | 7,570 | D |
| Bizily Scott Chief Legal Officer | 2024-03-27 | Sale 10b5-1 | −5,833 | $35.04 | $204,410 | 1,737 | D |
| Derivatives | |||||||
| Bizily Scott Chief Legal Officer | 2024-03-27 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −4,342 | 55,658 | D | ||
| Bizily Scott Chief Legal Officer | 2024-03-27 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,491 | 54,167 | D | ||
| Open-market sales · 5,833 sh · avg $35.04 · $204,410 | |||||||
Loading xslF345X05/ownership.xml…